Kim Forest Enterprise Co., Ltd.
Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company offers genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It also provides bioinformatics service items; prenatal test kits; and genetically modified model… Read more
Kim Forest Enterprise Co., Ltd. (6645) - Net Assets
Latest net assets as of December 2025: NT$514.08 Million TWD
Based on the latest financial reports, Kim Forest Enterprise Co., Ltd. (6645) has net assets worth NT$514.08 Million TWD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.02 Billion) and total liabilities (NT$503.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$514.08 Million |
| % of Total Assets | 50.51% |
| Annual Growth Rate | 25.87% |
| 5-Year Change | -5.13% |
| 10-Year Change | 235.34% |
| Growth Volatility | 53.23 |
Kim Forest Enterprise Co., Ltd. - Net Assets Trend (2013–2025)
This chart illustrates how Kim Forest Enterprise Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Kim Forest Enterprise Co., Ltd. (2013–2025)
The table below shows the annual net assets of Kim Forest Enterprise Co., Ltd. from 2013 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$514.08 Million | -19.18% |
| 2024-12-31 | NT$636.04 Million | +10.06% |
| 2023-12-31 | NT$577.92 Million | -0.75% |
| 2022-12-31 | NT$582.27 Million | +7.46% |
| 2021-12-31 | NT$541.86 Million | +20.19% |
| 2020-12-31 | NT$450.83 Million | +117.76% |
| 2019-12-31 | NT$207.03 Million | -13.34% |
| 2018-12-31 | NT$238.91 Million | -12.90% |
| 2017-12-31 | NT$274.30 Million | +78.93% |
| 2016-12-31 | NT$153.30 Million | +32.03% |
| 2015-12-31 | NT$116.11 Million | +39.36% |
| 2014-12-31 | NT$83.32 Million | +156.43% |
| 2013-12-31 | NT$32.49 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Kim Forest Enterprise Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11064.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | NT$608.64 Million | 124.00% |
| Other Comprehensive Income | NT$14.83 Million | 3.02% |
| Other Components | NT$15.63 Million | 3.18% |
| Total Equity | NT$490.86 Million | 100.00% |
Kim Forest Enterprise Co., Ltd. Competitors by Market Cap
The table below lists competitors of Kim Forest Enterprise Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Themis Medicare Limited
NSE:THEMISMED
|
$20.41 Million |
|
Global Graphics PLC
BR:HYSG
|
$20.42 Million |
|
Black Canyon Ltd
AU:BCA
|
$20.42 Million |
|
Cactus Acquisition Corp 1 Ltd
NASDAQ:CCTS
|
$20.42 Million |
|
P.C.S. Machine Group Holding Public Company Limited
BK:PCSGH
|
$20.40 Million |
|
Israel Canada
TA:ISCN
|
$20.40 Million |
|
United Polyfab Gujarat Limited
NSE:UNITEDPOLY
|
$20.40 Million |
|
Sh E & Chemical Co. Ltd.
KO:002360
|
$20.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kim Forest Enterprise Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 636,043,000 to 490,856,000, a change of -145,187,000 (-22.8%).
- Net loss of 146,450,000 reduced equity.
- Share repurchases of 5,144,000 reduced equity.
- Other comprehensive income increased equity by 14,387,000.
- Other factors decreased equity by 7,980,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-146.45 Million | -29.84% |
| Share Repurchases | NT$5.14 Million | -1.05% |
| Other Comprehensive Income | NT$14.39 Million | +2.93% |
| Other Changes | NT$-7.98 Million | -1.63% |
| Total Change | NT$- | -22.83% |
Book Value vs Market Value Analysis
This analysis compares Kim Forest Enterprise Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.79x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.40x to 1.79x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | NT$10.35 | NT$14.50 | x |
| 2015-12-31 | NT$6.96 | NT$14.50 | x |
| 2016-12-31 | NT$6.56 | NT$14.50 | x |
| 2017-12-31 | NT$9.11 | NT$14.50 | x |
| 2018-12-31 | NT$6.89 | NT$14.50 | x |
| 2019-12-31 | NT$6.16 | NT$14.50 | x |
| 2020-12-31 | NT$10.35 | NT$14.50 | x |
| 2021-12-31 | NT$10.87 | NT$14.50 | x |
| 2022-12-31 | NT$11.76 | NT$14.50 | x |
| 2023-12-31 | NT$11.90 | NT$14.50 | x |
| 2024-12-31 | NT$11.78 | NT$14.50 | x |
| 2025-12-31 | NT$8.09 | NT$14.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kim Forest Enterprise Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -29.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -26.67%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 2.07x
- Recent ROE (-29.84%) is below the historical average (-5.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 2.50% | 1.10% | 0.70x | 3.21x | NT$-6.25 Million |
| 2015 | 8.68% | 3.76% | 0.83x | 2.77x | NT$-1.53 Million |
| 2016 | 6.23% | 3.64% | 0.81x | 2.12x | NT$-5.78 Million |
| 2017 | 3.22% | 3.34% | 0.57x | 1.69x | NT$-18.60 Million |
| 2018 | -12.86% | -13.25% | 0.45x | 2.16x | NT$-54.61 Million |
| 2019 | -15.40% | -11.78% | 0.54x | 2.43x | NT$-52.58 Million |
| 2020 | -5.80% | -8.63% | 0.51x | 1.32x | NT$-71.23 Million |
| 2021 | 16.51% | 14.89% | 0.81x | 1.37x | NT$35.27 Million |
| 2022 | 7.28% | 6.33% | 0.79x | 1.45x | NT$-15.81 Million |
| 2023 | -17.73% | -24.69% | 0.43x | 1.68x | NT$-160.26 Million |
| 2024 | -25.14% | -31.88% | 0.44x | 1.79x | NT$-223.48 Million |
| 2025 | -29.84% | -26.67% | 0.54x | 2.07x | NT$-195.54 Million |
Industry Comparison
This section compares Kim Forest Enterprise Co., Ltd.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $563,992,667
- Average return on equity (ROE) among peers: 1.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kim Forest Enterprise Co., Ltd. (6645) | NT$514.08 Million | 2.50% | 0.98x | $20.40 Million |
| Bionet (1784) | $1.32 Billion | 2.02% | 0.36x | $107.18 Million |
| DIVA Laboratories Ltd (4153) | $1.02 Billion | 4.89% | 0.23x | $25.67 Million |
| Welgene Biotech Co.Ltd. (6661) | $246.55 Million | 11.49% | 0.47x | $3.31 Million |
| Puriblood Medical Co., Ltd. (6847) | $175.40 Million | -3.06% | 0.48x | $13.28 Million |
| TFBS Bioscience Inc. (6939) | $247.95 Million | 0.12% | 0.16x | $5.40K |
| Pharmigene, Inc. (7595) | $382.22 Million | -6.13% | 0.10x | $10.10 Million |